 | • レポートコード：GIR-202A2449 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アナフィラキシー治療注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アナフィラキシー治療注射の種類別市場規模（エピネフリン自動注射器、エピネフリン塩酸塩注射剤、その他）、用途別市場規模（6歳以下患者、6〜12歳患者、12歳以上患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アナフィラキシー治療注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Viatris、Teva Pharmaceutica、ALK Abello、Amneal Pharmaceuticals、Kaléo、Bioprojet Pharma、Bausch Health、Novartis Sandoz、Shanghai Harvest Pharmaceutical、Grand Pharmaceutical Group、TianJin KingYork Group、Beijing Yongkang Pharmaceutical、Livealth Biopharma、Teligent、Hameln Pharma、Nephron Pharmaceuticals Corporation、AdvaCare Pharma、Adamis Pharmaceuticals Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エピネフリン自動注射器、エピネフリン塩酸塩注射剤、その他 ・用途別分析2016年-2026年：6歳以下患者、6〜12歳患者、12歳以上患者 ・アナフィラキシー治療注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アナフィラキシー治療注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アナフィラキシー治療注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アナフィラキシー治療注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アナフィラキシー治療注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anaphylaxis Treatment Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Anaphylaxis Treatment Injection size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Anaphylaxis Treatment Injection market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Anaphylaxis Treatment Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epinephrine Auto-Injectors
Epinephrine Hydrochlaride Injection
Others
Market segment by Application can be divided into
Under 6 Years Patients
6 to 12 Years Patients
Over 12 Years Patients
The key market players for global Anaphylaxis Treatment Injection market are listed below:
Viatris
Teva Pharmaceutica
ALK Abello
Amneal Pharmaceuticals
Kaléo
Bioprojet Pharma
Bausch Health
Novartis Sandoz
Shanghai Harvest Pharmaceutical
Grand Pharmaceutical Group
TianJin KingYork Group
Beijing Yongkang Pharmaceutical
Livealth Biopharma
Teligent
Hameln Pharma
Nephron Pharmaceuticals Corporation
AdvaCare Pharma
Adamis Pharmaceuticals Corporation
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Anaphylaxis Treatment Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anaphylaxis Treatment Injection, with price, sales, revenue and global market share of Anaphylaxis Treatment Injection from 2019 to 2021.
Chapter 3, the Anaphylaxis Treatment Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anaphylaxis Treatment Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Anaphylaxis Treatment Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Anaphylaxis Treatment Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anaphylaxis Treatment Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anaphylaxis Treatment Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Epinephrine Auto-Injectors
1.2.3 Epinephrine Hydrochlaride Injection
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anaphylaxis Treatment Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Under 6 Years Patients
1.3.3 6 to 12 Years Patients
1.3.4 Over 12 Years Patients
1.4 Global Anaphylaxis Treatment Injection Market Size & Forecast
1.4.1 Global Anaphylaxis Treatment Injection Sales in Value (2016-2026))
1.4.2 Global Anaphylaxis Treatment Injection Sales in Volume (2016-2026)
1.4.3 Global Anaphylaxis Treatment Injection Price by Type (2016-2026) & (US$/Unit)
1.5 Global Anaphylaxis Treatment Injection Production Capacity Analysis
1.5.1 Global Anaphylaxis Treatment Injection Total Production Capacity (2016-2026)
1.5.2 Global Anaphylaxis Treatment Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anaphylaxis Treatment Injection Market Drivers
1.6.2 Anaphylaxis Treatment Injection Market Restraints
1.6.3 Anaphylaxis Treatment Injection Trends Analysis
2 Manufacturers Profiles
2.1 Viatris
2.1.1 Viatris Details
2.1.2 Viatris Major Business
2.1.3 Viatris Anaphylaxis Treatment Injection Product and Services
2.1.4 Viatris Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva Pharmaceutica
2.2.1 Teva Pharmaceutica Details
2.2.2 Teva Pharmaceutica Major Business
2.2.3 Teva Pharmaceutica Anaphylaxis Treatment Injection Product and Services
2.2.4 Teva Pharmaceutica Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 ALK Abello
2.3.1 ALK Abello Details
2.3.2 ALK Abello Major Business
2.3.3 ALK Abello Anaphylaxis Treatment Injection Product and Services
2.3.4 ALK Abello Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Amneal Pharmaceuticals
2.4.1 Amneal Pharmaceuticals Details
2.4.2 Amneal Pharmaceuticals Major Business
2.4.3 Amneal Pharmaceuticals Anaphylaxis Treatment Injection Product and Services
2.4.4 Amneal Pharmaceuticals Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Kaléo
2.5.1 Kaléo Details
2.5.2 Kaléo Major Business
2.5.3 Kaléo Anaphylaxis Treatment Injection Product and Services
2.5.4 Kaléo Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bioprojet Pharma
2.6.1 Bioprojet Pharma Details
2.6.2 Bioprojet Pharma Major Business
2.6.3 Bioprojet Pharma Anaphylaxis Treatment Injection Product and Services
2.6.4 Bioprojet Pharma Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bausch Health
2.7.1 Bausch Health Details
2.7.2 Bausch Health Major Business
2.7.3 Bausch Health Anaphylaxis Treatment Injection Product and Services
2.7.4 Bausch Health Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novartis Sandoz
2.8.1 Novartis Sandoz Details
2.8.2 Novartis Sandoz Major Business
2.8.3 Novartis Sandoz Anaphylaxis Treatment Injection Product and Services
2.8.4 Novartis Sandoz Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Shanghai Harvest Pharmaceutical
2.9.1 Shanghai Harvest Pharmaceutical Details
2.9.2 Shanghai Harvest Pharmaceutical Major Business
2.9.3 Shanghai Harvest Pharmaceutical Anaphylaxis Treatment Injection Product and Services
2.9.4 Shanghai Harvest Pharmaceutical Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Grand Pharmaceutical Group
2.10.1 Grand Pharmaceutical Group Details
2.10.2 Grand Pharmaceutical Group Major Business
2.10.3 Grand Pharmaceutical Group Anaphylaxis Treatment Injection Product and Services
2.10.4 Grand Pharmaceutical Group Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 TianJin KingYork Group
2.11.1 TianJin KingYork Group Details
2.11.2 TianJin KingYork Group Major Business
2.11.3 TianJin KingYork Group Anaphylaxis Treatment Injection Product and Services
2.11.4 TianJin KingYork Group Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Beijing Yongkang Pharmaceutical
2.12.1 Beijing Yongkang Pharmaceutical Details
2.12.2 Beijing Yongkang Pharmaceutical Major Business
2.12.3 Beijing Yongkang Pharmaceutical Anaphylaxis Treatment Injection Product and Services
2.12.4 Beijing Yongkang Pharmaceutical Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Livealth Biopharma
2.13.1 Livealth Biopharma Details
2.13.2 Livealth Biopharma Major Business
2.13.3 Livealth Biopharma Anaphylaxis Treatment Injection Product and Services
2.13.4 Livealth Biopharma Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Teligent
2.14.1 Teligent Details
2.14.2 Teligent Major Business
2.14.3 Teligent Anaphylaxis Treatment Injection Product and Services
2.14.4 Teligent Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Hameln Pharma
2.15.1 Hameln Pharma Details
2.15.2 Hameln Pharma Major Business
2.15.3 Hameln Pharma Anaphylaxis Treatment Injection Product and Services
2.15.4 Hameln Pharma Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Nephron Pharmaceuticals Corporation
2.16.1 Nephron Pharmaceuticals Corporation Details
2.16.2 Nephron Pharmaceuticals Corporation Major Business
2.16.3 Nephron Pharmaceuticals Corporation Anaphylaxis Treatment Injection Product and Services
2.16.4 Nephron Pharmaceuticals Corporation Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 AdvaCare Pharma
2.17.1 AdvaCare Pharma Details
2.17.2 AdvaCare Pharma Major Business
2.17.3 AdvaCare Pharma Anaphylaxis Treatment Injection Product and Services
2.17.4 AdvaCare Pharma Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Adamis Pharmaceuticals Corporation
2.18.1 Adamis Pharmaceuticals Corporation Details
2.18.2 Adamis Pharmaceuticals Corporation Major Business
2.18.3 Adamis Pharmaceuticals Corporation Anaphylaxis Treatment Injection Product and Services
2.18.4 Adamis Pharmaceuticals Corporation Anaphylaxis Treatment Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Anaphylaxis Treatment Injection Sales by Manufacturer
3.1 Global Anaphylaxis Treatment Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Anaphylaxis Treatment Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Anaphylaxis Treatment Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Anaphylaxis Treatment Injection Manufacturer Market Share
3.4.2 Top 6 Anaphylaxis Treatment Injection Manufacturer Market Share
3.5 Global Anaphylaxis Treatment Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Anaphylaxis Treatment Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anaphylaxis Treatment Injection Market Size by Region
4.1.1 Global Anaphylaxis Treatment Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Anaphylaxis Treatment Injection Revenue by Region (2016-2026)
4.2 North America Anaphylaxis Treatment Injection Revenue (2016-2026)
4.3 Europe Anaphylaxis Treatment Injection Revenue (2016-2026)
4.4 Asia-Pacific Anaphylaxis Treatment Injection Revenue (2016-2026)
4.5 South America Anaphylaxis Treatment Injection Revenue (2016-2026)
4.6 Middle East and Africa Anaphylaxis Treatment Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Anaphylaxis Treatment Injection Sales in Volume by Type (2016-2026)
5.2 Global Anaphylaxis Treatment Injection Revenue by Type (2016-2026)
5.3 Global Anaphylaxis Treatment Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Anaphylaxis Treatment Injection Sales in Volume by Application (2016-2026)
6.2 Global Anaphylaxis Treatment Injection Revenue by Application (2016-2026)
6.3 Global Anaphylaxis Treatment Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Anaphylaxis Treatment Injection Sales by Type (2016-2026)
7.2 North America Anaphylaxis Treatment Injection Sales by Application (2016-2026)
7.3 North America Anaphylaxis Treatment Injection Market Size by Country
7.3.1 North America Anaphylaxis Treatment Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Anaphylaxis Treatment Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Anaphylaxis Treatment Injection Sales by Type (2016-2026)
8.2 Europe Anaphylaxis Treatment Injection Sales by Application (2016-2026)
8.3 Europe Anaphylaxis Treatment Injection Market Size by Country
8.3.1 Europe Anaphylaxis Treatment Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Anaphylaxis Treatment Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Anaphylaxis Treatment Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Anaphylaxis Treatment Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Anaphylaxis Treatment Injection Market Size by Region
9.3.1 Asia-Pacific Anaphylaxis Treatment Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Anaphylaxis Treatment Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Anaphylaxis Treatment Injection Sales by Type (2016-2026)
10.2 South America Anaphylaxis Treatment Injection Sales by Application (2016-2026)
10.3 South America Anaphylaxis Treatment Injection Market Size by Country
10.3.1 South America Anaphylaxis Treatment Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Anaphylaxis Treatment Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anaphylaxis Treatment Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Anaphylaxis Treatment Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Anaphylaxis Treatment Injection Market Size by Country
11.3.1 Middle East & Africa Anaphylaxis Treatment Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Anaphylaxis Treatment Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Anaphylaxis Treatment Injection Typical Distributors
12.3 Anaphylaxis Treatment Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Anaphylaxis Treatment Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Anaphylaxis Treatment Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Viatris Basic Information, Manufacturing Base and Competitors
Table 4. Viatris Major Business
Table 5. Viatris Anaphylaxis Treatment Injection Product and Services
Table 6. Viatris Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutica Major Business
Table 9. Teva Pharmaceutica Anaphylaxis Treatment Injection Product and Services
Table 10. Teva Pharmaceutica Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ALK Abello Basic Information, Manufacturing Base and Competitors
Table 12. ALK Abello Major Business
Table 13. ALK Abello Anaphylaxis Treatment Injection Product and Services
Table 14. ALK Abello Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Pharmaceuticals Major Business
Table 17. Amneal Pharmaceuticals Anaphylaxis Treatment Injection Product and Services
Table 18. Amneal Pharmaceuticals Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Kaléo Basic Information, Manufacturing Base and Competitors
Table 20. Kaléo Major Business
Table 21. Kaléo Anaphylaxis Treatment Injection Product and Services
Table 22. Kaléo Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bioprojet Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Bioprojet Pharma Major Business
Table 25. Bioprojet Pharma Anaphylaxis Treatment Injection Product and Services
Table 26. Bioprojet Pharma Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 28. Bausch Health Major Business
Table 29. Bausch Health Anaphylaxis Treatment Injection Product and Services
Table 30. Bausch Health Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Sandoz Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Sandoz Major Business
Table 33. Novartis Sandoz Anaphylaxis Treatment Injection Product and Services
Table 34. Novartis Sandoz Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Shanghai Harvest Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai Harvest Pharmaceutical Major Business
Table 37. Shanghai Harvest Pharmaceutical Anaphylaxis Treatment Injection Product and Services
Table 38. Shanghai Harvest Pharmaceutical Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Grand Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 40. Grand Pharmaceutical Group Major Business
Table 41. Grand Pharmaceutical Group Anaphylaxis Treatment Injection Product and Services
Table 42. Grand Pharmaceutical Group Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. TianJin KingYork Group Basic Information, Manufacturing Base and Competitors
Table 44. TianJin KingYork Group Major Business
Table 45. TianJin KingYork Group Anaphylaxis Treatment Injection Product and Services
Table 46. TianJin KingYork Group Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Beijing Yongkang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Beijing Yongkang Pharmaceutical Major Business
Table 49. Beijing Yongkang Pharmaceutical Anaphylaxis Treatment Injection Product and Services
Table 50. Beijing Yongkang Pharmaceutical Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Livealth Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Livealth Biopharma Major Business
Table 53. Livealth Biopharma Anaphylaxis Treatment Injection Product and Services
Table 54. Livealth Biopharma Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Teligent Basic Information, Manufacturing Base and Competitors
Table 56. Teligent Major Business
Table 57. Teligent Anaphylaxis Treatment Injection Product and Services
Table 58. Teligent Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Hameln Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Hameln Pharma Major Business
Table 61. Hameln Pharma Anaphylaxis Treatment Injection Product and Services
Table 62. Hameln Pharma Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Nephron Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 64. Nephron Pharmaceuticals Corporation Major Business
Table 65. Nephron Pharmaceuticals Corporation Anaphylaxis Treatment Injection Product and Services
Table 66. Nephron Pharmaceuticals Corporation Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. AdvaCare Pharma Basic Information, Manufacturing Base and Competitors
Table 68. AdvaCare Pharma Major Business
Table 69. AdvaCare Pharma Anaphylaxis Treatment Injection Product and Services
Table 70. AdvaCare Pharma Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Adamis Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 72. Adamis Pharmaceuticals Corporation Major Business
Table 73. Adamis Pharmaceuticals Corporation Anaphylaxis Treatment Injection Product and Services
Table 74. Adamis Pharmaceuticals Corporation Anaphylaxis Treatment Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Anaphylaxis Treatment Injection Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Anaphylaxis Treatment Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Anaphylaxis Treatment Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Anaphylaxis Treatment Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Anaphylaxis Treatment Injection Production Site of Key Manufacturer
Table 80. Anaphylaxis Treatment Injection New Entrant and Capacity Expansion Plans
Table 81. Anaphylaxis Treatment Injection Mergers & Acquisitions in the Past Five Years
Table 82. Global Anaphylaxis Treatment Injection Sales by Region (2016-2021e) & (K Units)
Table 83. Global Anaphylaxis Treatment Injection Sales by Region (2021-2026) & (K Units)
Table 84. Global Anaphylaxis Treatment Injection Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Anaphylaxis Treatment Injection Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 87. Global Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 88. Global Anaphylaxis Treatment Injection Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Anaphylaxis Treatment Injection Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Anaphylaxis Treatment Injection Price by Type (2016-2021e) & (US$/Unit)
Table 91. Global Anaphylaxis Treatment Injection Price by Type (2021-2026) & (US$/Unit)
Table 92. Global Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 93. Global Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 94. Global Anaphylaxis Treatment Injection Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Anaphylaxis Treatment Injection Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Anaphylaxis Treatment Injection Price by Application (2016-2021e) & (US$/Unit)
Table 97. Global Anaphylaxis Treatment Injection Price by Application (2021-2026) & (US$/Unit)
Table 98. North America Anaphylaxis Treatment Injection Sales by Country (2016-2021e) & (K Units)
Table 99. North America Anaphylaxis Treatment Injection Sales by Country (2021-2026) & (K Units)
Table 100. North America Anaphylaxis Treatment Injection Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Anaphylaxis Treatment Injection Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 103. North America Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 104. North America Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 105. North America Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 106. Europe Anaphylaxis Treatment Injection Sales by Country (2016-2021e) & (K Units)
Table 107. Europe Anaphylaxis Treatment Injection Sales by Country (2021-2026) & (K Units)
Table 108. Europe Anaphylaxis Treatment Injection Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Anaphylaxis Treatment Injection Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 111. Europe Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 112. Europe Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 113. Europe Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 114. Asia-Pacific Anaphylaxis Treatment Injection Sales by Region (2016-2021e) & (K Units)
Table 115. Asia-Pacific Anaphylaxis Treatment Injection Sales by Region (2021-2026) & (K Units)
Table 116. Asia-Pacific Anaphylaxis Treatment Injection Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Anaphylaxis Treatment Injection Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 119. Asia-Pacific Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 120. Asia-Pacific Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 121. Asia-Pacific Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 122. South America Anaphylaxis Treatment Injection Sales by Country (2016-2021e) & (K Units)
Table 123. South America Anaphylaxis Treatment Injection Sales by Country (2021-2026) & (K Units)
Table 124. South America Anaphylaxis Treatment Injection Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Anaphylaxis Treatment Injection Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 127. South America Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 128. South America Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 129. South America Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 130. Middle East & Africa Anaphylaxis Treatment Injection Sales by Country (2016-2021e) & (K Units)
Table 131. Middle East & Africa Anaphylaxis Treatment Injection Sales by Country (2021-2026) & (K Units)
Table 132. Middle East & Africa Anaphylaxis Treatment Injection Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Anaphylaxis Treatment Injection Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Anaphylaxis Treatment Injection Sales by Type (2016-2021e) & (K Units)
Table 135. Middle East & Africa Anaphylaxis Treatment Injection Sales by Type (2021-2026) & (K Units)
Table 136. Middle East & Africa Anaphylaxis Treatment Injection Sales by Application (2016-2021e) & (K Units)
Table 137. Middle East & Africa Anaphylaxis Treatment Injection Sales by Application (2021-2026) & (K Units)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Anaphylaxis Treatment Injection Typical Distributors
Table 141. Anaphylaxis Treatment Injection Typical Customers
List of Figures
Figure 1. Anaphylaxis Treatment Injection Picture
Figure 2. Global Anaphylaxis Treatment Injection Sales Market Share by Type in 2020
Figure 3. Epinephrine Auto-Injectors
Figure 4. Epinephrine Hydrochlaride Injection
Figure 5. Others
Figure 6. Global Anaphylaxis Treatment Injection Sales Market Share by Application in 2020
Figure 7. Under 6 Years Patients
Figure 8. 6 to 12 Years Patients
Figure 9. Over 12 Years Patients
Figure 10. Global Anaphylaxis Treatment Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Anaphylaxis Treatment Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Anaphylaxis Treatment Injection Sales (2016-2026) & (K Units)
Figure 13. Global Anaphylaxis Treatment Injection Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Anaphylaxis Treatment Injection Production Capacity (2016-2026) & (K Units)
Figure 15. Global Anaphylaxis Treatment Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Anaphylaxis Treatment Injection Market Drivers
Figure 17. Anaphylaxis Treatment Injection Market Restraints
Figure 18. Anaphylaxis Treatment Injection Market Trends
Figure 19. Global Anaphylaxis Treatment Injection Sales Market Share by Manufacturer in 2020
Figure 20. Global Anaphylaxis Treatment Injection Revenue Market Share by Manufacturer in 2020
Figure 21. Anaphylaxis Treatment Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Anaphylaxis Treatment Injection Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Anaphylaxis Treatment Injection Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Anaphylaxis Treatment Injection Sales Market Share by Region (2016-2026)
Figure 25. Global Anaphylaxis Treatment Injection Revenue Market Share by Region (2016-2026)
Figure 26. North America Anaphylaxis Treatment Injection Revenue (2016-2026) & (USD Million)
Figure 27. Europe Anaphylaxis Treatment Injection Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Anaphylaxis Treatment Injection Revenue (2016-2026) & (USD Million)
Figure 29. South America Anaphylaxis Treatment Injection Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Anaphylaxis Treatment Injection Revenue (2016-2026) & (USD Million)
Figure 31. Global Anaphylaxis Treatment Injection Sales Market Share by Type (2016-2026)
Figure 32. Global Anaphylaxis Treatment Injection Revenue Market Share by Type (2016-2026)
Figure 33. Global Anaphylaxis Treatment Injection Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 35. Global Anaphylaxis Treatment Injection Revenue Market Share by Application (2016-2026)
Figure 36. Global Anaphylaxis Treatment Injection Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Anaphylaxis Treatment Injection Sales Market Share by Type (2016-2026)
Figure 38. North America Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 39. North America Anaphylaxis Treatment Injection Sales Market Share by Country (2016-2026)
Figure 40. North America Anaphylaxis Treatment Injection Revenue Market Share by Country (2016-2026)
Figure 41. United States Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Anaphylaxis Treatment Injection Sales Market Share by Type (2016-2026)
Figure 45. Europe Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 46. Europe Anaphylaxis Treatment Injection Sales Market Share by Country (2016-2026)
Figure 47. Europe Anaphylaxis Treatment Injection Revenue Market Share by Country (2016-2026)
Figure 48. Germany Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Anaphylaxis Treatment Injection Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Anaphylaxis Treatment Injection Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Anaphylaxis Treatment Injection Revenue Market Share by Region (2016-2026)
Figure 57. China Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Anaphylaxis Treatment Injection Sales Market Share by Type (2016-2026)
Figure 64. South America Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 65. South America Anaphylaxis Treatment Injection Sales Market Share by Country (2016-2026)
Figure 66. South America Anaphylaxis Treatment Injection Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Anaphylaxis Treatment Injection Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Anaphylaxis Treatment Injection Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Anaphylaxis Treatment Injection Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Anaphylaxis Treatment Injection Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Anaphylaxis Treatment Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の10％デキストロース注射市場 2021：企業別、地域別、種類・用途別 The 10% Dextrose Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の5％デキストロース注射市場 2021：企業別、地域別、種類・用途別 The 5% Dextrose Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の骨注射用複合ペプチド市場 2021：企業別、地域別、種類・用途別 The Compound Bone Peptide for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界のアンモニア注入グリッド（AIG）市場 2021：企業別、地域別、種類・用途別 The Ammonia Injection Grid (AIG) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のアセトアミノフェン注射市場 2021：企業別、地域別、種類・用途別 The Acetaminophen Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…